日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study

SYN008 与奥马珠单抗治疗难治性慢性自发性荨麻疹患者的等效性:一项多中心、随机、双盲、平行组、活性对照的 III 期研究

Li, Jingyi; Liang, Yunsheng; Feng, Wenli; Deng, Liehua; Fang, Hong; Ji, Chao; Lin, Youkun; Zhang, Furen; Xia, Rushan; Zhang, Chunlei; Guo, Shuping; Lin, Mao; Li, Yanling; Zhang, Shoumin; Kang, Xiaojing; Chen, Liuqing; Song, Zhiqiang; Yao, Xu; Li, Chengxin; Han, Xiuping; Guo, Guoxiang; Guo, Qing; Duan, Xinsuo; Li, Jie; Su, Juan; Li, Shanshan; Sun, Qing; Tao, Juan; Ding, Yangfeng; Deng, Danqi; Li, Fuqiu; Suo, Haiyun; Wu, Shunquan; Qiu, Jingbo; Luo, Hongmei; Li, Linfeng; Li, Ruoyu

Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy

半合成靶向 CaMKIIγ:cMyc 轴的贝沙维和贝巴明衍生物用于淋巴瘤治疗

Lujan, Berkley; Zhang, Mingfeng; Cao, Yujie; Kacker, Arnav; Mai, Lina; Wu, Shunquan; Alexander, Taylor; Huang, Wendong; Kou, Kevin G M

The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial

在中国18岁及以上受试者中,使用SARS-CoV-2 mRNA疫苗(SYS6006)进行异源加强免疫的安全性、免疫原性和有效性:一项随机、开放标签、活性对照的3期临床试验

Zhou, Chunhua; Qiu, Yuanzheng; Wang, Jianxin; Zhong, Xiang; Zhu, Xiufang; Huang, Xiaojing; Yang, Lan; Ji, Qiaolei; Zhou, Feifei; Wu, Shunquan; Yang, Mengjie; Zhang, Jing; Liu, Kaili; Ji, Li; Yang, Hanyu; Li, Chunlei; Zhao, Yuanyuan

Pharmacological profiling of a berbamine derivative for lymphoma treatment

用于淋巴瘤治疗的黄连素衍生物的药理学分析

Xu, Senlin; Wu, Shunquan; Zhang, Mingfeng; Xie, Jun; Lin, Min; Jin, Lihua; Zhang, Jiawei; Wang, Yangmeng; Fan, Mingjie; Fang, Zhipeng; Li, Weini; Ouyang, Ching; Kwon, David; Que, Natalie; Li, Zhirou; Mao, Jinge; Chen, Haonan; Harris, Josephine; Wu, Xiwei; Wu, Jun; Yin, Hongwei; Chan, Wing C; Horne, David; Huang, Wendong

Efficacy and safety of tandem autologous stem cell transplantation in multiple myeloma: a retrospective single-center analysis

自体干细胞串联移植治疗多发性骨髓瘤的疗效和安全性:一项回顾性单中心分析

Wu, Shunquan; Qiu, Zongjian; Lin, Ting; Zhu, Zhijuan; Li, Xiaofan; Chen, Xianling; Chen, Ping; Wang, Yiting; Zhan, Rong; Li, Nainong

A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells.

miRNA介导的肝细胞和库普弗细胞中肝癌发生的减弱

Tian Yan, Zhang Mingfeng, Fan Mingjie, Xu Haixia, Wu Shunquan, Zou Sailan, Wang Yangmeng, Tang Dongmei, Zhang Chunyan, Han Weidong, Yu Hua, Fu Xianghui, Huang Wendong

Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study

贝利木单抗静脉和皮下单剂量自动注射器给药在健康中国志愿者中的药代动力学和安全性:一项1期随机、开放标签研究

Meng, Xianmin; Wang, Qianqian; Wu, Shunquan; Pu, Di; Zhang, Amber; Fang, Sun; Zhou, Xuan; Lu, Hongzhou

Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study

每日一次吸入乌美溴铵治疗亚洲慢性阻塞性肺疾病患者的疗效和安全性:一项随机、安慰剂对照研究的结果

Zhong, Nanshan; Zheng, Jinping; Lee, Sang Haak; Lipson, David A; Du, Xin; Wu, Shunquan

A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma

一种基于胶原凝胶液滴嵌入三维培养方法的肝细胞癌新型化疗敏感性检测系统

Hou, Jun; Hong, Zhixian; Feng, Fan; Chai, Yantao; Zhang, Yunkai; Jiang, Qiyu; Hu, Yan; Wu, Shunquan; Wu, Yingsong; Gao, Xunian; Chen, Qiong; Wan, Yong; Bi, Jingfeng; Zhang, Zheng

High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.

磷酸化细胞外信号调节激酶(ERK1/2)高表达与新诊断的多发性骨髓瘤患者预后不良相关

Fan Liping, Hong Jinquan, Huang Haobo, Fu Danhui, Wu Shunquan, Wang Qingqing, Ye Yamei, Liu Yun